KCL study reveals particles in cows’ milk effective for oral delivery of RNA drugs
The method has the potential to be used to deliver RNA to the bloodstream for a range of diseases
Read More
Tag: RNA
AZ, Accent to develop therapies targeting RNA-modifying proteins
These proteins control various aspects of RNA biology and represent a new target for cancer treatment
Read More
BI signs deal with MiNA to develop liver disease drugs
Boehringer Ingelheim has signed a second deal focused on the development of RNA therapeutics for liver diseases.
Read More
Cambridge Uni spin-off raises £12m for cancer therapeutics
Cambridge University spin-off Storm Therapeutics has secured £12 million in series ‘A’ funding to advance its work on targeting enzymes that modify RNA to generate novel cancer therapeutics.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
